Skip to main content

Leadership

2006 News Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006
DateTitle  
12/21/06Emergent BioSolutions to Present at JPMorgan Healthcare Conference Printer Friendly Version
12/21/06National Institutes of Health to Sponsor Clinical Trial for Emergent BioSolutions' Group B Streptococcus Vaccine Candidate Printer Friendly Version
12/20/06Emergent BioSolutions Applauds Passage and Signing of BARDA Legislation Printer Friendly Version
12/14/06Emergent BioSolutions Delivers over 3 Million Doses of BioThrax(R) to U.S. Department of Health and Human Services for Strategic National Stockpile Printer Friendly Version
11/21/06Emergent BioSolutions Celebrates Initial Public Offering; CEO To Ring Opening Bell on the NYSE Printer Friendly Version
11/15/06Emergent BioSolutions Announces Pricing of Its Initial Public Offering Printer Friendly Version
08/31/06Emergent BioSolutions Awarded Two Grants From NIAID To Support Development Of Anthrax Immune Globulin Therapeutic Printer Friendly Version
08/29/06U.S. Department Of Homeland Security Certifies BioThrax® (Anthrax Vaccine Adsorbed) As An Approved Product For Homeland Security Printer Friendly Version
08/15/06Emergent BioSolutions Inc. Files Registration Statement For Proposed Initial Public Offering Printer Friendly Version
08/03/06Emergent BioSolutions Expands Presence In Germany Printer Friendly Version
07/21/06Cornerstone Ceremony Welcomes New Vaccine Production Facility To Michigan Printer Friendly Version
07/12/06Joe M. Allbaugh, Former FEMA Director, Joins Emergent BioSolutions’ Board Of Directors Printer Friendly Version
06/21/06Former DHHS Secretary, Dr. Louis W. Sullivan, Joins Board Of Directors Of Emergent BioSolutions Printer Friendly Version
06/05/06Emergent BioSolutions Signs Agreement with sanofi pasteur for Development of Novel Meningitis B Vaccine Printer Friendly Version
05/05/06DHHS Expands Emergent BioSolutions’ Contract To Supply BioThrax To The Strategic National Stockpile Printer Friendly Version
02/14/06Emergent BioSolutions Announces Investments In Manufacturing Capability  Printer Friendly Version
01/10/06New Studies Conclude BioThrax Plus Antibiotics Provide 100% Protection In Animals When Administered After Anthrax Exposure Printer Friendly Version